Driehaus Capital Management LLC Pmv Pharmaceuticals, Inc. Transaction History

Driehaus Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$19.99 - $30.24 $699,650 - $1.06 Million	-35,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.84 - $36.58 $939,400 - $1.28 Million	35,000 New	35,000 $1.04 Million
Q2 2021 Aug 16, 2021	SELL	$28.01 - $36.01 $6.03 Million - $7.75 Million	-215,307 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$30.66 - $49.5 $506,165 - $817,195	-16,509 Reduced 7.12%	215,307 $7.08 Million
Q4 2020 Feb 16, 2021	SELL	$31.86 - $61.51 $183,099 - $353,497	-5,747 Reduced 2.42%	231,816 $14.3 Million
Q3 2020 Nov 16, 2020	BUY	$35.5 - $38.0 $8.43 Million - $9.03 Million	237,563 New	237,563 $8.43 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $72.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.